Brief report on the experience of using proxy consent for incapacitated adults

The Medicines for Human Use (Clinical Trials) Regulations 2004, which came into force in the UK in May 2004, cover the conduct of clinical trials on medicinal products. They allow a legal representative (a person not connected with the conduct of the trial) to consent to the participation of incompe...

Full description

Saved in:  
Bibliographic Details
Authors: Mason, S. (Author) ; Barrow, H. (Author) ; Phillips, A. (Author) ; Eddison, G. (Author) ; Nelson, A. (Author) ; Cullum, N. (Author) ; Nixon, J. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2006
In: Journal of medical ethics
Year: 2006, Volume: 32, Issue: 1, Pages: 61-62
Online Access: Volltext (JSTOR)
Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000naa a22000002 4500
001 1816129976
003 DE-627
005 20220908053421.0
007 cr uuu---uuuuu
008 220908s2006 xx |||||o 00| ||eng c
024 7 |a 10.1136/jme.2005.012302  |2 doi 
035 |a (DE-627)1816129976 
035 |a (DE-599)KXP1816129976 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Mason, S.  |e VerfasserIn  |4 aut 
245 1 0 |a Brief report on the experience of using proxy consent for incapacitated adults 
264 1 |c 2006 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a The Medicines for Human Use (Clinical Trials) Regulations 2004, which came into force in the UK in May 2004, cover the conduct of clinical trials on medicinal products. They allow a legal representative (a person not connected with the conduct of the trial) to consent to the participation of incompetent adults in medical research. Currently, very little is known about how such representatives will make their decisions. We have experience with proxy consent for older adults in a large, national trial. From 2445 potentially eligible but incapacitated patients, proxy, relative assent resulted in trial participation of only 87 (3.6%) patients. The reasons for this were that a large number of incapacitated patients had no relative available for assent (2286), but also a high proportion of relatives approached refused to provide assent (72/159, 45.3%). In comparison, 17.7% of patients declined participation in the trial. Proxy consent allowed only a small increase in trial recruitment of incapacitated patients. The fact that a greater proportion of relatives than patients refused to provide assent implies that they were more cautious than the patients themselves, or perhaps used different criteria, when making their decision. In future research involving incapacitated older patients there is likely to be heavy reliance on proxy consent provision by legal representatives. Our findings imply that consent decisions of legal representatives will not necessarily reflect those of patients themselves. 
700 1 |a Barrow, H.  |e VerfasserIn  |4 aut 
700 1 |a Phillips, A.  |e VerfasserIn  |4 aut 
700 1 |a Eddison, G.  |e VerfasserIn  |4 aut 
700 1 |a Nelson, A.  |e VerfasserIn  |4 aut 
700 1 |a Cullum, N.  |e VerfasserIn  |4 aut 
700 1 |a Nixon, J.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 32(2006), 1, Seite 61-62  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:32  |g year:2006  |g number:1  |g pages:61-62 
856 |3 Volltext  |u http://www.jstor.org/stable/27719559  |x JSTOR 
856 |u https://jme.bmj.com/content/medethics/32/1/61.full.pdf  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via free pdf)] 
856 4 0 |u https://doi.org/10.1136/jme.2005.012302  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/32/1/61.abstract  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185583834 
LOK |0 003 DE-627 
LOK |0 004 1816129976 
LOK |0 005 20220908053421 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-02#A6C8A2ECC306C7C40FF8F7FB79526FB9C867B5BB 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/27719559 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw